How to Order Prescriptions
LAVERDIA® (verdinexor tablets) is a prescription oral anticancer medication indicated for the treatment of lymphoma in dogs. It belongs to a class of medications known as selective inhibitors of nuclear export (SINE), which work by targeting proteins involved in tumor cell survival. LAVERDIA® is designed to selectively affect cancer cells while helping preserve normal cells.Available in four tablet strengths, LAVERDIA® is administered twice weekly with food using a veterinarian-prescribed dosing schedule. Treatment should always be supervised by a veterinarian experienced in cancer therapy and requires routine monitoring for adverse effects and laboratory abnormalities.
Uses & Benefits
- FDA-approved for the treatment of lymphoma in dogs
- Oral alternative to injectable chemotherapy protocols
- Targets cancer cells through selective inhibition of nuclear export
- Convenient twice-weekly dosing schedule
- Available in multiple tablet strengths for individualized treatment
- May provide longer time to disease progression compared to placebo
- Can be used in both treatment-naïve and relapsed lymphoma patients under veterinary supervision
